CH655934A5 - 5-Alkylpyrimidine nucleosides - Google Patents
5-Alkylpyrimidine nucleosides Download PDFInfo
- Publication number
- CH655934A5 CH655934A5 CH1693/81A CH169381A CH655934A5 CH 655934 A5 CH655934 A5 CH 655934A5 CH 1693/81 A CH1693/81 A CH 1693/81A CH 169381 A CH169381 A CH 169381A CH 655934 A5 CH655934 A5 CH 655934A5
- Authority
- CH
- Switzerland
- Prior art keywords
- fluorouracil
- formula
- alkyl
- thymidine
- thymine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19803010397 DE3010397A1 (de) | 1980-03-18 | 1980-03-18 | Verwendung von 5-alkyl-pyrimidinnukleosiden als cytostatika |
Publications (1)
Publication Number | Publication Date |
---|---|
CH655934A5 true CH655934A5 (en) | 1986-05-30 |
Family
ID=6097574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1693/81A CH655934A5 (en) | 1980-03-18 | 1981-03-12 | 5-Alkylpyrimidine nucleosides |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS56140921A (ja) |
CA (1) | CA1162853A (ja) |
CH (1) | CH655934A5 (ja) |
DE (1) | DE3010397A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58152898A (ja) * | 1982-03-08 | 1983-09-10 | Taiho Yakuhin Kogyo Kk | 2′−デオキシ−5−トリフルオロメチルウリジン誘導体、その製法およびそれを含む抗腫瘍剤 |
HU196038B (en) * | 1987-08-07 | 1988-09-28 | Mta Koezponti Kemiai Kutato In | Process for producing antiherpetic pharmaceutics for external use, containing 5-isopropyl-2'-beta-deoxy-uridine |
US5268365A (en) * | 1988-03-11 | 1993-12-07 | Rudolph Frederick B | Nucleotides, nucleosides, and nucleobases in immune function restoration enhancement or maintenance |
ATA173599A (de) * | 1999-10-14 | 2001-04-15 | Lilly Co Eli | Pharmazeutisches produkt |
-
1980
- 1980-03-18 DE DE19803010397 patent/DE3010397A1/de not_active Withdrawn
-
1981
- 1981-03-12 CH CH1693/81A patent/CH655934A5/de not_active IP Right Cessation
- 1981-03-12 JP JP3642881A patent/JPS56140921A/ja active Pending
- 1981-03-18 CA CA000373253A patent/CA1162853A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE3010397A1 (de) | 1981-10-29 |
JPS56140921A (en) | 1981-11-04 |
CA1162853A (en) | 1984-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3587500T2 (de) | Tumorbehandlung bei Säugetieren. | |
DE69302360T2 (de) | N-Oxycarbonyl substitutierte 5'-Deoxy-5-Fluorocytidin | |
DE69721339T2 (de) | Monozyklische l-nukleoside, analoga und ihre anwendungen | |
DE68923387T2 (de) | 2',3'-Dideoxy-2',2'-difluornucleoside. | |
DE3850571T2 (de) | 2',3'-dideoxyribofuranoxid-derivate. | |
DE3852288T2 (de) | K-252-Derivate mit Antitumorwirkung und diese enthaltende Arzneimittel. | |
EP0545966B1 (de) | Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel | |
EP0316704B1 (de) | Fluorcytidinderivate, deren Herstellung und Arzneimittel, die diese Derivate enthalten | |
EP0484333B1 (de) | Nucleosid-derivate und deren verwendung als arzneimittel | |
DE2915254C2 (ja) | ||
WO1993016092A1 (de) | Neue lipidphosphonsäure-nucleosid-konjugate sowie deren verwendung als antivirale arzneimittel | |
EP0056265B1 (de) | 5'-Ester von Pyrimidinnucleosiden mit antiviraler Wirksamkeit, Verfahren zur Herstellung und daraus hergestellte Arzneimittel | |
WO1993016091A1 (de) | Neue liponucleotide, deren herstellung sowie deren verwendung als antivirale arzneimittel | |
DE69029733T2 (de) | Nukleosidderivate von 2-halo-9(2-oxy-2-fluoro-beta-d-arabinofuranosyl)adenin | |
DE3739366A1 (de) | Desaza-purin-nucleosid-derivate, verfahren zu deren herstellung sowie deren verwendung bei der nucleinsaeure-sequenzierung sowie als antivirale mittel | |
EP0003229A1 (de) | Neues Verfahren zur Herstellung von Nucleosiden | |
WO1996032403A2 (de) | Neue cytosin- und cytidinderivate | |
EP0817790B1 (de) | Spezifische lipidkonjugate von nucleosid-diphosphaten und deren verwendung als arzneimittel | |
DE2858078C2 (de) | 2-Chlorethylnitrosoharnstoffe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen | |
DE3508356C2 (ja) | ||
DE68918036T2 (de) | Nukleosid-Derivate. | |
CH655934A5 (en) | 5-Alkylpyrimidine nucleosides | |
DE68917060T2 (de) | 2'-Methylidenpyrimidin-Nukleoside, ihre Verwendung und Verfahren zu ihrer Herstellung. | |
EP0614462B1 (de) | Neues verfahren zur herstellung von 2-fluorpurin-derivaten | |
DE2601755C2 (de) | Pseudoisocytidin und dessen Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |